Literature DB >> 10233478

Endocrine treatment of prostate cancer - recent developments and the future. Part 1: maximal androgen blockade, early vs delayed endocrine treatment and side-effects.

F H Schröder1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10233478     DOI： 10.1046/j.1464-410x.1999.00955.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  3 in total

Review 1.  Prostate cancer.

Authors:  D Mazhar; J Waxman
Journal:  Postgrad Med J       Date:  2002-10       Impact factor: 2.401

2.  Risk of the "androgen deprivation syndrome" in men receiving androgen deprivation for prostate cancer.

Authors:  Vahakn B Shahinian; Yong-Fang Kuo; Jean L Freeman; James S Goodwin
Journal:  Arch Intern Med       Date:  2006-02-27

3.  The impact of adjuvant therapy in patients with biochemical recurrence on prostate cancer progression and mortality five years after radical prostatectomy.

Authors:  Mieczysław Fryczkowski; Piotr Bryniarski; Maciej Szczębara; Marian Suchodolski; Andrzej Paradysz
Journal:  Cent European J Urol       Date:  2011-12-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.